Histoplasmosis in an off-trail Hiker receiving ustekinumab: Implications for Preventive and diagnostic strategies for patients receiving anti-IL-12/23 therapy.

Huang, Yun-Han; Magleby, Reed; Rao, Rema; Walsh, Thomas J; Singh, Harjot K

Huang, Yun-Han; Magleby, Reed; Rao, Rema; Walsh, Thomas J; Singh, Harjot K.

Afiliación

Huang YH; Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program, 1300 York Ave, New York, NY, 10065, USA.
Magleby R; Weill Cornell Medicine, Division of Infectious Diseases, 1305 York Ave, New York, NY, 10021, USA.
Rao R; Weill Cornell Medicine, Pathology and Laboratory Medicine, 1300 York Ave, New York, NY, 10065, USA.
Walsh TJ; Weill Cornell Medicine, Division of Infectious Diseases, 1305 York Ave, New York, NY, 10021, USA.
Singh HK; Weill Cornell Medicine, Division of Infectious Diseases, 1305 York Ave, New York, NY, 10021, USA.

Med Mycol Case Rep ; 32: 43-46, 2021 Jun.

Article en En | MEDLINE | ID: mdl-33816098

Palabras clave

Histoplasmosis; Immunosuppression; Ustekinumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Med Mycol Case Rep Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google